Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer

被引：0
|
作者：
Danielsson, O. [1 ]
Dar, H. A. [1 ]
Nordenskjold, A. [2 ]
Tenorio, G. Perez [3 ,4 ]
Yau, C. [5 ]
Benz, C. [6 ]
Van't Veer, L. J. [7 ]
Esserman, L. [5 ]
Nordenskjold, B. A. [3 ,4 ]
Fornander, T. [1 ]
Stal, O. [3 ,4 ]
Tobin, N. P. [1 ]
Johansson, A. [1 ]
Lindstrom, L. S. [1 ]
机构：
[1] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
[2] Sahlgrens Acad, Dept Oncol, Gothenburg, Sweden
[3] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden
[4] Linkoping Univ, Dept Oncol, Linkoping, Sweden
[5] UCSF Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[6] UCSF Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] UCSF Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
瑞典研究理事会;
关键词：
D O I：
10.1016/j.annonc.2024.08.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页码：S346 / S346
页数：1
相关论文
共 50 条
  • [1] Long-Term Benefit from Adjuvant Tamoxifen in Luminal A and Luminal B Breast Cancer Patients
    Dar, Huma
    Johansson, Annelie
    Nordenskjold, Anna
    Perez-Tenorio, Gizeh
    Yau, Christina
    Benz, Christopher C.
    Esserman, Laura J.
    Nordenskjold, Bo
    Stal, Olle
    Fornander, Tommy
    Lindstrom, Linda S.
    CANCER RESEARCH, 2023, 83 (05)
  • [2] Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
    Yu, Nancy Y.
    Iftimi, Adina
    Yau, Christina
    Tobin, Nicholas P.
    van 't Veer, Laura
    Hoadley, Katherine A.
    Benz, Christopher C.
    Nordenskjold, Bo
    Fornander, Tommy
    Stal, Olle
    Czene, Kamila
    Esserman, Laura J.
    Lindstrom, Linda S.
    JAMA ONCOLOGY, 2019, 5 (09) : 1304 - 1309
  • [3] Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.
    Lindstrom, Linda
    Yu, Nancy
    Iftimi, Adina
    Yau, Christina
    van 't Veer, Laura
    Nordenskjold, Bo
    Benz, Christopher
    Fornander, Tommy
    Stal, Olle
    Czene, Kamila
    Esserman, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] The tamoxifen paradoxinfluence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer
    Kyvernitakis, I.
    Kostev, K.
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (11) : 2557 - 2564
  • [5] Long-term excess body fat in adulthood and the risk of pre- and postmenopausal breast cancer in Chinese women
    Hao, Yu
    Xu, Bin
    Yan, Qiming
    Zhou, Min
    Hou, Can
    Wu, Lin
    Zhong, Xiaorong
    Li, Jiayuan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 195 - 206
  • [6] Long-term excess body fat in adulthood and the risk of pre- and postmenopausal breast cancer in Chinese women
    Yu Hao
    Bin Xu
    Qiming Yan
    Min Zhou
    Can Hou
    Lin Wu
    Xiaorong Zhong
    Jiayuan Li
    Breast Cancer Research and Treatment, 2020, 182 : 195 - 206
  • [7] The tamoxifen paradox—influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer
    I. Kyvernitakis
    K. Kostev
    P. Hadji
    Osteoporosis International, 2018, 29 : 2557 - 2564
  • [8] Dietary lignans and risk of pre- and postmenopausal breast cancer
    McCann, SE
    Muti, P
    Trevisan, M
    Vito, D
    Ram, M
    Freudenheim, JL
    FASEB JOURNAL, 2002, 16 (04): : A248 - A248
  • [9] Risk of endometrial cancer in breast cancer patients under long-term adjuvant treatment with tamoxifen
    Cecchini, S
    Ciatto, S
    Bonardi, R
    Mazzotta, A
    Pacini, P
    Muraca, MG
    Zappa, M
    TUMORI JOURNAL, 1998, 84 (01): : 21 - 23
  • [10] Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy
    Markovitch, O.
    Tepper, R.
    Fishman, A.
    Aviram, R.
    Cohen, Ilan
    MATURITAS, 2008, 59 (04) : 387 - 393
12345